Lincoln Pharmaceuticals Ltd Share Price Today Live NSE/BSE

Investment Ratings

As per analysts rating in the last 6 months, the recommendation is to HOLD Lincoln Pharma.

Master Rating:
Lincoln Pharmaceuticals has an operating revenue of Rs. 439.71 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 20% is great, ROE of 16% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 84 which is a GOOD score indicating consistency in earnings, a RS Rating of 51 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 146 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Lincoln Pharmaceuticals Ltd Forecast

Price Estimates

2,000(9.8%)

1,758(-3.5%)

1,590(-12.7%)

Ratings

Eps And Sales Estimates

Sales(Cr) EPS

Lincoln Pharmaceuticals Ltd Synopsis

NSE-Medical-Diversified

Lincoln Pharmace is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 413.06 Cr. and Equity Capital is Rs. 20.00 Cr. for the Year ended 31/03/2021. Lincoln Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 20/01/1995 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1995PLC024288 and registration number is 024288.

Market Cap

INR 695.64 Cr
Sales

INR 435.11 Cr
Shares in Float

1.20 Cr
No of Funds

9 K

Yield

0.43%
Book Value

1.9
U/D Vol Ratio

1.1

LTDebt/Equity

0%
Alpha

0.06
Beta

0.97

Lincoln Pharmaceuticals Ltd Ownership

Owner Name	Jun-21	Mar-21	Dec-20
Promoters	37.78%	37.26%	33.41%
Foreign Portfolio Investors	0.01%	0%	0%
Financial Institutions/ Banks	0%	0%	0%
Individual Investors	40.52%	42.89%	45.32%
Others	21.69%	19.85%	21.27%

Lincoln Pharmaceuticals Ltd Management

Name	Designation
Mr. Kishor M Shah	Chairman
Mr. Mahendra G Patel	Managing Director
Mr. Hashmukh I Patel	Whole Time Director
Mr. Munjal M Patel	Whole Time Director
Mr. Ashish R Patel	Whole Time Director
Mr. Arvind G Patel	Director
Mr. Rajnikant G Patel	Director
Mr. Ishwarlal A Patel	Independent Director
Mr. Pirabhai R Suthar	Independent Director
Mr. Meha M Patel	Independent Director
Mr. Saurin J Parikh	Independent Director

Lincoln Pharmaceuticals Ltd Financials

Standalone Consolidated

Quarterly P&L
Annual P&L
Cash Flow
Balance Sheet
Ratios

INDICATOR	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020
Oper Rev Qtr Cr	125.64033	119.73748	77.5405	112.1923	122.2895
Operating Expenses Qtr Cr	97.4612	95.74939	63.3066	93.3168	94.48953
Operating Profit Qtr Cr	28.17913	23.98809	14.2339	18.8755	27.79997
Depreciation Qtr Cr	1.51291	1.43963	1.4179	1.4222	1.42022
Interest Qtr Cr	0.20279	0.37523	0.5336	0.3611	0.20661
Tax Qtr Cr	7.35461	7.11664	2.9402	4.7885	7.19507
Net Profit Qtr Cr	22.88138	17.37794	11.8494	13.3683	20.19755

INDICATOR	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Total Revenue Annual Cr	419.8213	388.2192	359.61793	330.75806	306.73454
Operating Expenses Annual Cr	331.7052	316.7195	292.71307	278.99606	261.72874
Operating Profit Annual in Cr	81.35	59.3688	60.32943	45.95823	42.55093
Depreciation Cr	5.6659	5.4695	4.91913	4.3993	3.85167
Interest Annual Cr	1.4378	1.9836	3.84354	4.26466	5.41272
Tax Annual Cr	20.6063	14.483	11.50513	10.34151	8.33857
Net Profit Annual Cr	60.4061	49.5636	46.63707	32.75652	27.40283

INDICATOR	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Cash from Operating Activity Annual Cr	71.41	70.71	51.0584	17.75547	17.79966
Cash from Investing Activity Annual Cr	-64.9126	-28.9927	-22.31467	-10.08098	-25.89778
Cash from Financing Annual Activity Cr	-5.2949	-38.1038	-29.88307	-4.16071	8.05067
Net Cash Flow Annual Cr	1.2025	3.6135	-1.13934	3.51378	-0.04745

INDICATOR	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Total ShareHolders Funds Annual Cr	364.9531	304.4949	262.60411	219.54031	189.58043
Fixed Assets Annual Cr	91.2419	91.0667	90.39284	83.23868	74.70276
Total Non Current Assets Annual Cr	162.965	151.8325	152.2666	135.76386	127.83945
Total Current Assets Annual Cr	275.7244	215.3762	194.52118	190.24422	153.91844
Total Assets Annual Cr	438.6894	367.2087	346.78778	326.00808	281.7579

INDICATOR	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Book Value Per Share Annual Rs	182.476	152.247	131.302	109.77	94.79
ROE Annual %	16.55	16.27	17.75	14.92	14.45
ROCE Annual %	22.12	21.18	22.86	20.13	20.03
Total Debt to Total Equity Annual	-	-	-	-	-
EBDIT Annual Margin %	21.33	19.01	18.95	15.92	14.79

Quarterly P&L
Annual P&L
Cash Flow
Balance Sheet
Ratios

INDICATOR	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020
Oper Rev Qtr Cr			79.5804	114.7471	126.0643
Operating Expenses Qtr Cr			64.3362	94.7454	96.2999
Operating Profit Qtr Cr			15.2442	20.0017	29.7644
Depreciation Qtr Cr			1.8916	1.8959	1.8945
Interest Qtr Cr			0.5747	0.3916	-0.0786
Tax Qtr Cr			2.7294	4.9602	7.6279
Net Profit Qtr Cr			12.5729	13.4818	20.9119

INDICATOR	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Total Revenue Annual Cr	429.8494	397.5307	371.83182	366.06801	362.99228
Operating Expenses Annual Cr	337.0067	320.9545	298.9612	308.29809	313.48159
Operating Profit Annual in Cr	87.1788	65.536	67.21982	52.3162	46.77642
Depreciation Cr	7.5603	7.3262	6.67904	6.11181	5.51484
Interest Annual Cr	1.5619	2.0176	3.99706	5.41101	6.66148
Tax Annual Cr	21.4708	15.7661	13.4557	11.59769	9.2008
Net Profit Annual Cr	62.2236	51.4392	48.71006	34.62296	28.12323

INDICATOR	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Cash from Operating Activity Annual Cr	69.2698	75.4152	52.8446	23.14791	25.04138
Cash from Investing Activity Annual Cr	-64.2271	-30.8826	-18.1875	-8.28743	-25.48405
Cash from Financing Annual Activity Cr	-5.7456	-37.7589	-35.7682	-11.40821	0.30246
Net Cash Flow Annual Cr	-0.7029	6.7737	-1.1111	3.45227	-0.14021

INDICATOR	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Total ShareHolders Funds Annual Cr	375.292	313.0889	269.34453	224.21795	192.38491
Fixed Assets Annual Cr	112.3241	113.535	113.77699	107.64096	100.11619
Total Non Current Assets Annual Cr	152.9158	141.3907	144.43937	128.8989	124.28995
Total Current Assets Annual Cr	306.4559	247.9971	220.80362	218.33619	181.04943
Total Assets Annual Cr	459.3717	389.3878	365.24298	347.2351	305.33937

INDICATOR	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Book Value Per Share Annual Rs	187.849	156.735	134.849	112.272	96.342
ROE Annual %	16.58	16.42	18.08	15.44	14.61
ROCE Annual %	22.1	21.38	23.58	21.31	20.51
Total Debt to Total Equity Annual	-	-	-	-	-
EBDIT Annual Margin %	21.88	19.81	19.9	16.01	13.74

Lincoln Pharmaceuticals Ltd Technicals

EMA & SMA

CURRENT PRICE

347.3 (7.37)

- Bullish Moving Averages 13
- Bearish Moving Averages 3

EMA

EMA SMA

20 Day

337.53
50 Day

347.95
100 Day

342.16
200 Day

312.82

Lincoln Pharmaceuticals Ltd Resistance and support

329.8 PIVOT

First Resistance

337.5
Second Resistance

351.55
Third Resistance

359.25

First Support

315.75
Second Support

308.05
Third Support

294

RSI

53.37
MFI

50.31

MACD

-7.29
MACD signal line

-8.75

Lincoln Pharmaceuticals Ltd Delivery and Volume

Period	NSE + BSE Volume Avg	NSE + BSE Delivery Volume Avg	NSE + BSE Delivery Volume %
Day	406,621	12,869,555	31.65%
Week	183,064	7,104,714	38.81%
1 Month	138,867	5,422,749	39.05%
6 Month	277,320	10,668,485	38.47%

Lincoln Pharmaceuticals Ltd Price change analysis

4.1

Over 1 month

Low High

309 370.25

18.85

Over 3 month

Low High

309 414.75

51.75

Over 6 months

Low High

282 414.75

112.85

Over Year

Low High

191.4 414.75